SAFE Act

The SAFE Act creates a new category of "fentanyl-related substances" that would automatically be controlled under Schedule I of the Controlled Substances Act based on specific chemical modifications to fentanyl. This affects anyone involved in the production, distribution, or use of substances meeting this broad definition. The bill establishes a process for removing or rescheduling these substances if they're determined to have less potential for abuse than Schedule I substances, and allows courts to review past convictions involving substances that have since been removed from this category. It also creates new research procedures for Schedule I substances and requires a GAO report analyzing the law's implementation and impact within four years.